to study the effect of calcium and vitamin D supplementation in children with leukemia

To study the effect of oral calcium and vitamin D3 supplementation on bone mineral density in children with acute lymphoblastic leukemia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150119020715N7

Enrollment

Registered

2018-06-30

Start date

2018-05-04

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leukemia. Acute lymphoblastic leukemia [ALL]

Interventions

Intervention 1: Intervention group: In addition to chemotherapy drugs, patients receive 30-40 mg/kg calcium and 400 units per day of vitamin D. Intervention 2: Control group: For the control group mem

Eligibility

Sex/Gender

All

Age

5 Years to 15 Years

Inclusion criteria

Inclusion criteria: All of the children with acute lymphoblastic leukemia above 5 years old

Exclusion criteria

Exclusion criteria: Patients with no compliance with using supplements Patients with no satisfaction to continue the study No compliance with enteric use of supplements Not doing bone marrow densitometry

Design outcomes

Primary

Measure	Time frame
Bone mineral density. Timepoint: in the beginning of the study (before the intervention) and 6 months after the intervention. Method of measurement: Bone Mineral Densitometry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Aziz Eghbali

Arak University of Medical Sciences

aziz_eghbali@yahoo.com+98 86 3313 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026